Firefly Neuroscience, Inc.
Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product,…
1D
-7.3%
1W
-14.3%
1M
+9.7%
6M
-42.0%
YTD
+16.6%
1Y
-61.2%
2Y
-75.1%
5Y
-98.9%
10Y
-77.3%
Next earnings date
No date known
Volatility around earnings
~20% weaker price swings than usual
P/E
-1.6
P/B
1.43
EV/EBITDA
-0.76
RETURN ON EQUITY
-13.5%
NET MARGIN
-386.0%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
90.3%
FLOAT SHARES
14,160,667
AVG. DAILY VOLUME (30D)
5,584,972
Firefly Neuroscience, Inc. is a company in the Technology sector, Software - Application industry, headquartered in United States.
The CEO is Greg Lipschitz, the company employs around 17 people.
The IPO was on 28/11/2002; the stock trades on NASDAQ under the ticker AIFF.
Around past earnings, price swings were roughly -20% stronger than usual.
No, Firefly Neuroscience currently does not pay a dividend.
Comparable stocks include Salesforce, ServiceNow, Uber Technologies, Snowflake, Automatic Data Processing, Datadog, Cadence Design Systems and Adobe.
Clicking "Analyze stock" lets five strategies assess Firefly Neuroscience against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.